Medication treatment quality startup MDI Health filled a $20 million Series A round, CEO Avishai Ben-Tovim tells Axios exclusively.
Why it matters: Adverse drug reactions, a leading cause of death in the U.S., happen when clinicians and prescribers lack adequate information about patient health. MDI seeks to make that information more readily available.
